Aurora Cannabis (TSE:ACB) Shares Up 0.2% – What’s Next?

Aurora Cannabis Inc. (TSE:ACB)’s stock price was up 0.2% during trading on Thursday . The company traded as high as C$5.97 and last traded at C$5.90. Approximately 506,480 shares were traded during mid-day trading, a decline of 17% from the average daily volume of 611,648 shares. The stock had previously closed at C$5.89.

Analysts Set New Price Targets

Separately, ATB Capital reduced their target price on Aurora Cannabis from C$9.00 to C$8.50 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Strong Buy” and a consensus price target of C$8.50.

Aurora Cannabis Stock Down 0.2%

The stock has a market cap of C$333.23 million, a price-to-earnings ratio of -5.77 and a beta of 0.71. The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72. The stock has a fifty day moving average of C$6.33 and a two-hundred day moving average of C$6.68.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings results on Wednesday, November 5th. The company reported C($0.91) EPS for the quarter. The firm had revenue of C$90.37 million for the quarter. Aurora Cannabis had a negative return on equity of 8.36% and a negative net margin of 22.55%. As a group, analysts predict that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.